ARCHIVES

FDA Grants Priority Review To Two Drugs in NSCLC

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

August 11, 1989

More Radiation Increases Prostate Cancer Response

August 30, 2002

NCI Programs: Institute Renews 10 Center Grants, Provides Complete Grant List.

January 28, 2005

NCI Grants Payline Could Reach 175 Under Final Fiscal 1985 Awards Level Of Approximately 1,000

August 9, 1985

Cancer Information Available By Fax

May 3, 1991

In Brief: Administration “Streamlining” Accomplished; DCCR contract Merit Review In Open Session

February 24, 1978